Michael “Mike” Mahoney is Chief Executive Officer of Boston Scientific Corporation and Chairman of the company’s Board of Directors. Boston Scientific is a global medical technology leader with more than $8 billion in annual revenue and commercial representation in more than 100 countries. Under Mahoney’s leadership, Boston Scientific is delivering on its mission to transform lives through innovative medical solutions that improve the health of patients around the world. The company’s team of more than 25,000 global employees reaches 22 million patients each year, providing a range of technologies and solutions that span cardiovascular and peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation and urology and pelvic health. Mahoney joined Boston Scientific in 2011 as President, and became President, Chief Executive Officer and a member of the Board of Directors in 2012. He was elected Chairman in 2016.

Cardiology, Cardiovascular Diseases, cardiovascular and peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation and urology and pelvic health.